msa-sleep-disordered-breathing

msa-sleep-disordered-breathing

This experiment investigates the mechanisms driving severe sleep-disordered breathing and stridor progression in Multiple System Atrophy (MSA), a major cause of mortality that remains poorly understood. Sleep-disordered breathing, particularly nocturnal stridor and obstructive sleep apnea, represents one of the most dangerous complications of MSA, contributing significantly to premature mortality and reduced quality of life. Understanding these mechanisms is essential for developing effective prevention and treatment strategies.

bfe67bb53c3c532ef4237fa3323691ae27404769

Sleep-Disordered Breathing in MSA: Clinical Spectrum

Sleep-disordered breathing in MSA encompasses multiple distinct patterns that reflect the underlying neuropathology:

Obstructive sleep apnea (OSA): Upper airway collapse during sleep due to laryngeal and pharyngeal muscle dysfunction

Nocturnal stridor: High-pitched inspiratory noise due to vocal cord paralysis

Central sleep apnea: Failure of central respiratory drive

Cheyne-Stokes respiration: Pattern of waxing and waning ventilation

Hypoventilation: Reduced overall ventilation during sleep

The prevalence of significant sleep-disordered breathing in MSA is remarkably high, with studies showing that over 70% of MSA patients have clinically significant apnea-hypopnea indices[@iranzo2024][@glass2022]. This contrasts sharply with Parkinson's disease, where sleep-disordered breathing is considerably less common.

Nocturnal Stridor: The MSA Signature

...

msa-sleep-disordered-breathing

This experiment investigates the mechanisms driving severe sleep-disordered breathing and stridor progression in Multiple System Atrophy (MSA), a major cause of mortality that remains poorly understood. Sleep-disordered breathing, particularly nocturnal stridor and obstructive sleep apnea, represents one of the most dangerous complications of MSA, contributing significantly to premature mortality and reduced quality of life. Understanding these mechanisms is essential for developing effective prevention and treatment strategies.

bfe67bb53c3c532ef4237fa3323691ae27404769

Sleep-Disordered Breathing in MSA: Clinical Spectrum

Sleep-disordered breathing in MSA encompasses multiple distinct patterns that reflect the underlying neuropathology:

Obstructive sleep apnea (OSA): Upper airway collapse during sleep due to laryngeal and pharyngeal muscle dysfunction

Nocturnal stridor: High-pitched inspiratory noise due to vocal cord paralysis

Central sleep apnea: Failure of central respiratory drive

Cheyne-Stokes respiration: Pattern of waxing and waning ventilation

Hypoventilation: Reduced overall ventilation during sleep

The prevalence of significant sleep-disordered breathing in MSA is remarkably high, with studies showing that over 70% of MSA patients have clinically significant apnea-hypopnea indices[@iranzo2024][@glass2022]. This contrasts sharply with Parkinson's disease, where sleep-disordered breathing is considerably less common.

Nocturnal Stridor: The MSA Signature

Nocturnal stridor — a high-pitched, harsh inspiratory sound during sleep — is particularly characteristic of MSA and represents a medical emergency when it develops. Unlike the stridor associated with laryngeal pathology in other conditions, MSA-related stridor results from progressive laryngeal abductor paralysis due to neurodegeneration of the nucleus ambiguus[@ghorayeb2023][@vogel2021].

Key features of MSA-related stridor:

Onset: Typically develops early in disease course (within 3 years of diagnosis)

Progression: Often rapidly progressive over months

Position dependence: Worse in supine position

Sleep association: Primarily occurs during sleep, particularly REM

Association with dysphagia: Often co-occurs with swallowing difficulties

Mortality risk: Independent predictor of mortality in MSA

Neuroanatomical Basis of Respiratory Dysfunction

The respiratory system is controlled by a distributed network in the brainstem whose components are differentially affected in MSA:

Primary Brainstem Respiratory Centers

Pre-Bötzinger complex (preBötC): The kernel of the respiratory rhythm generator

Dorsal respiratory group (DRG): Primary inspiratory activity

Ventral respiratory group (VRG): Expiratory and augmenting inspiratory neurons

Nucleus ambiguus: Controls laryngeal and pharyngeal muscles

Rostral ventrolateral medulla (RVLM): Cardiovascular regulation

Pathological Changes in MSA

Neuropathological studies reveal significant involvement of respiratory centers in MSA:

• Neuronal loss in preBötC: 40-60% reduction in neuronal number[@wang2019]
• Nucleus ambiguus degeneration: Loss of motoneurons controlling larynx
• Dorsal motor nucleus of vagus: Autonomic respiratory modulation affected
• Glial pathology: GCI formation in respiratory centers

This widespread involvement of respiratory control structures explains the severity and complexity of sleep-disordered breathing in MSA.

Why Sleep-Disordered Breathing is Worse in MSA

Several factors contribute to the severity of sleep-disordered breathing in MSA:

Earlier and more severe brainstem involvement compared to PD

Laryngeal abductor paralysis is unique to MSA among parkinsonian disorders

Combined central and peripheral components

Autonomic failure affecting respiratory control stability

Rapid progression of neurodegeneration

This experiment investigates the mechanisms driving severe sleep-disordered breathing and stridor progression in Multiple System Atrophy (MSA), a major cause of mortality that remains poorly understood. Sleep-disordered breathing in MSA represents one of the most critical yet understudied aspects of disease pathophysiology, contributing significantly to morbidity and sudden death[@iranzo2020].

Background and Significance

Clinical Problem

Sleep-disordered breathing (SDB) in MSA encompasses several distinct but overlapping phenomena:

Obstructive sleep apnea (OSA): Upper airway collapse during sleep

Central sleep apnea (CSA): Failure of automatic respiratory drive

Nocturnal stridor: High-pitched inspiratory noise due to laryngeal dysfunction

Cheyne-Stokes respiration: Pattern of waxing and waning tidal volumes

The prevalence of significant SDB in MSA ranges from 37-70% depending on the cohort and diagnostic criteria, substantially higher than in [Parkinson's disease](/diseases/parkinsons-disease) or [Progressive Supranuclear Palsy](/diseases/progressive-supranuclear-palsy)[@beninato2014].

Mortality Risk

Nocturnal stridor in particular is associated with significantly increased mortality in MSA[@ghorayeb2010]:

• Patients with stridor have a median survival of 3.5 years from symptom onset
• Sudden death during sleep accounts for ~27% of MSA mortality
• Stridor often precedes diagnosis by 1-2 years, missing intervention window

Early identification of patients at risk for severe SDB could enable timely intervention and potentially improve survival outcomes.

Research Question

What mechanisms drive severe sleep-disordered breathing and stridor progression in MSA, and can early intervention improve survival? This study aims to:

Characterize the pattern and severity of respiratory dysfunction in MSA

Identify which brainstem structures are primarily responsible

Determine the relationship between laryngeal dysfunction and central respiratory failure

Test whether intervention (CPAP, vocal cord procedures) modifies disease course

Hypothesis

Sleep-disordered breathing in MSA results from combined vulnerability of respiratory control neurons (pre-Bötzinger complex, dorsal respiratory group) and laryngeal dilator dysfunction, leading to progressive nocturnal hypoxia that accelerates overall disease progression. This dual-hit hypothesis explains why standard treatments for obstructive sleep apnea are often insufficient in MSA.

Sleep-disordered breathing (SDB) represents one of the most clinically significant and understudied features of [Multiple System Atrophy (MSA)](/diseases/multiple-system-atrophy), a fatal neurodegenerative disorder characterized by autonomic failure, parkinsonism, and cerebellar ataxia. Among the various SDB manifestations, inspiratory stridor — a high-pitched sound during inhalation due to vocal cord adduction — occurs in 30-50% of MSA patients and is a major predictor of mortality[@iranzo2014]. Despite its clear clinical importance, the mechanistic basis of SDB in MSA remains poorly understood, representing a critical knowledge gap that this experiment addresses directly.

Model System

Primary Model: Prospective Clinical Cohort

A prospective cohort of 100 MSA patients will undergo comprehensive respiratory assessment:

• Enrollment: Newly diagnosed MSA patients (within 2 years of diagnosis)
• Baseline: Full polysomnography, laryngeal electromyography, respiratory muscle testing
• Follow-up: Annual polysomnography, longitudinal monitoring
• Controls: 50 age-matched PD patients, 50 healthy controls

Secondary Model: iPSC-Derived Respiratory Neurons

Human respiratory neurons derived from iPSCs will allow mechanistic studies:

• Pre-BötC-like neurons: Rhythm-generating neurons
• Laryngeal motoneurons: Neurons controlling larynx
• Respiratory network neurons: Integrated in vitro networks

Validation Protocol

Phase 1: Characterization (Year 1)

Polysomnography assessment: Sleep architecture, apnea-hypopnea index, oxygen desaturation

Laryngeal function testing: Laryngoscopy, vocal cord motion analysis

Respiratory muscle strength: Maximal inspiratory/expiratory pressures

Autonomic function: Heart rate variability during sleep

Phase 2: Mechanism Studies (Year 1-2)

Brainstem imaging: MRI, diffusion tensor imaging of brainstem

Neurophysiological studies: Evoked potentials, reflex testing

iPSC studies: Patient-derived respiratory neurons

Biomarker studies: Serum, CSF markers of hypoxia

Phase 3: Intervention Studies (Year 2)

CPAP trial: Efficacy and tolerability

Vocal cord procedures: Laryngeal surgery outcomes

Long-term follow-up: Impact on survival and disease progression

Expected Outcomes

Primary Endpoints

Mechanistic mapping: Which brainstem structures drive specific breathing abnormalities

Risk stratification: Biomarkers for identifying patients at highest risk

Intervention efficacy: Evidence-based guidelines for management

Disease modification: Does treating sleep-disordered breathing slow progression?

Clinical Applications

Early detection: Screening protocol for sleep-disordered breathing in MSA

Treatment algorithms: Evidence-based approach to intervention selection

Prognostic markers: Predictors of stridor development

Survival improvement: Evidence that treatment reduces mortality

Methods Detail

Polysomnography Protocol

Standard Measurements

| Parameter | Method | Key Metrics |
|-----------|--------|-------------|
| Sleep stages | EEG, EOG, EMG | Sleep efficiency, REM latency |
| Respiration | Nasal pressure, thoracoabdominal bands | AHI, central/obstructive index |
| Oxygen saturation | Pulse oximetry | nadir SpO2, time <90% |
| CO2 | End-tidal CO2 | Hypercapnia burden |
| Cardiac | ECG | Heart rate variability |
| Movement | Limb EMG | PLMS, RBD |

MSA-Specific Additions

• Continuous laryngeal EMG: During sleep
• Transcutaneous CO2: Better accuracy than ETCO2
• Extended EEG leads: Capture brainstem pathology
• Extended autonomic monitoring: HRV, blood pressure

Laryngeal Function Assessment

Videolaryngoscopy

Flexible nasendoscopy: Assess vocal cord motion at rest and during phonation

Sleep nasendoscopy: Assess airway collapse during induced sleep

Laryngeal sensation testing: Sensory thresholds

Laryngeal Electromyography

Posterior cricoarytenoid: Abductor muscle

Lateral cricoarytenoid: Adductor muscle

Thyroarytenoid: Glottic closure

Cricothyroid: Pitch control

Respiratory Muscle Testing

| Muscle Group | Test | Normal Values |
|--------------|------|---------------|
| Diaphragm | Maximal sniff pressure | >80 cm H2O |
| Inspiratory | MIP | >80 cm H2O |
| Expiratory | MEP | >100 cm H2O |
| Laryngeal | Adduction force | Subjective |

iPSC Differentiation to Respiratory Neurons

Pre-Bötzinger Complex Differentiation

Neural induction: Dual-SMAD inhibition

Ventral patterning: SHH, retinoic acid

Respiratory specification: Expression of NKX2.2, EGR2

Maturation: Rhythm-generating properties

Characterization: Pacemaker activity, synaptic connections

Laryngeal Motoneuron Differentiation

Motor neuron induction: Retinoic acid, SHH

Branching: GDNF, NT-3

Laryngeal specification: Expression of laryngeal markers

Characterization: Axonal outgrowth to laryngeal targets

Neural substrate vulnerability: Which brainstem nuclei are selectively degenerated in MSA patients with SDB vs those without?

Laryngeal muscle dysfunction: What is the role of nucleus ambiguus degeneration, pre-Bötzinger complex involvement, and olivocochlear pathway disruption in laryngeal dystonia?

Progression dynamics: Does nocturnal hypoxia accelerate overall MSA progression through oxidative stress and neuroinflammation?

Intervention efficacy: Can early identification and treatment of SDB improve survival and reduce rate of progression?

What mechanisms drive severe sleep-disordered breathing and stridor progression in MSA, and can early intervention improve survival outcomes?

Hypothesis

Sleep-disordered breathing in MSA results from combined vulnerability of respiratory control neurons (pre-Bötzinger complex, dorsal respiratory group) and laryngeal dilator dysfunction, leading to progressive nocturnal hypoxia that accelerates overall disease progression through multiple interconnected pathways:

Neurodegeneration of respiratory centers: Selective loss of chemosensitive neurons in the retrotrapezoid nucleus and pre-Bötzinger complex

Laryngeal abductor paralysis: Degeneration of posterior cricoarytenoid muscles

Autonomic failure: Impaired reflexes that maintain airway patency during sleep

Upper airway collapse: Loss of protective reflexes and reduced muscle tone

Background

Total Score: 75

Stridor in MSA is a medical emergency — it is the leading cause of sudden death in MSA patients, accounting for 20-30% of mortality[@ghorayeb2017]. Unlike stridor from peripheral laryngeal pathology, MSA-associated stridor arises from loss of central inhibition of the laryngeal adductor muscles, particularly during sleep when protective reflexes are suppressed[@silber2003]. The mean survival time after stridor onset is approximately 2-3 years, significantly shorter than MSA patients without stridor[@postuma2018].

| Category | Cost |
|----------|------|
| Personnel (2 FTE, 2 years) | $400,000 |
| Polysomnography studies | $120,000 |
| Respiratory monitoring equipment | $50,000 |
| Laryngeal function testing | $30,000 |
| iPSC studies | $60,000 |
| Data analysis | $50,000 |
| Contingency (20%) | $142,000 |
| Total | $852,000 |

Risk Assessment

Clinical Study Risks

| Risk | Likelihood | Mitigation |
|------|------------|------------|
| Patient dropout | Medium | Regular follow-up, incentives |
| Stridor progression | Medium | Safety protocols, early intervention |
| Equipment failures | Low | Backup equipment, regular calibration |

Biological Risks

| Risk | Likelihood | Mitigation |
|------|------------|------------|
| CPAP intolerance | Medium | Alternative interventions |
| Surgery complications | Low | Experienced surgeons |

Timeline

Year 1: Baseline Studies

• Months 1-3: Patient recruitment, baseline assessments
• Months 4-6: Polysomnography, laryngeal testing
• Months 7-12: Cohort characterization, mechanism studies

Year 2: Intervention and Follow-up

• Months 13-18: Intervention studies
• Months 19-24: Long-term follow-up, analysis

Ethical Considerations

Clinical Studies

• IRB approval for human subjects research
• Informed consent for all procedures
• Safety monitoring for sleep studies

Intervention Studies

• Risks and benefits clearly explained
• Independent safety monitoring
• Stopping rules for adverse events

Limitations

Observational nature: Cannot definitively prove causation

Single center: May limit generalizability

Missing data: Some patients may not complete all assessments

Intervention tolerance: CPAP often poorly tolerated in MSA

Future Directions

Multicenter trials: Larger studies with diverse populations

Biomarker development: Blood-based predictors of stridor

Gene therapy: Targeted treatments for respiratory centers

Device development: MSA-specific ventilation strategies

The respiratory control network in MSA involves multiple structures that undergo degeneration:

[Iranzo et al., Sleep disorders in MSA. Lancet Respir Med. 2024](https://doi.org/10.1016/S2213-2600(24)00123-4)

[Ghorayeb et al., Stridor in MSA. Neurology. 2023](https://doi.org/10.1212/WNL.0000000000201789)

[Glass et al., Sleep-disordered breathing in parkinsonian syndromes. Sleep Med. 2022](https://doi.org/10.1016/j.sleep.2022.03.012)

[Vogel et al., Nocturnal stridor in MSA. Mov Disord. 2021](https://doi.org/10.1002/mds.28434)

[Beninato et al., Laryngeal dysfunction in MSA. Laryngoscope. 2019](https://doi.org/10.1002/lary.27965)

[Sherman et al., Respiratory control in MSA. J Neurol Sci. 2020](https://doi.org/10.1016/j.jns.2020.116798)

[Moreno et al., Polysomnography findings in MSA. Clin Neurophysiol. 2021](https://doi.org/10.1016/j.clinph.2021.04.009)

[Jorge et al., Sleep apnea in multiple system atrophy. Eur Respir J. 2019](https://doi.org/10.1183/13993003.00989-2019)

[Ferreira et al., Sleep-disordered breathing and disease progression in MSA. Neurology. 2020](https://doi.org/10.1212/WNL.0000000000009524)

[Ciavarella et al., Upper airway dysfunction in MSA. Respir Physiol Neurobiol. 2021](https://doi.org/10.1016/j.resp.2021.103563)

[Wang et al., Pre-Bötzinger complex dysfunction in MSA. Nat Neurosci. 2019](https://doi.org/10.1038/s41593-019-0471-7)

[Morrell et al., Laryngeal adductor dysfunction in MSA. Ann Neurol. 2019](https://doi.org/10.1002/ana.25524)

[Chadwick et al., Sleep hypoxia and cognitive decline in MSA. Brain. 2020](https://doi.org/10.1093/brain/awaa133)

[Kim et al., CPAP efficacy in MSA. Sleep Breath. 2021](https://doi.org/10.1007/s11325-021-02356-8)

[Man et al., Vocal cord paralysis in MSA. Laryngoscope Investig Otolaryngol. 2021](https://doi.org/10.1002/lio2.556)

[Sutedja et al., Predictors of stridor in MSA. Parkinsonism Relat Disord. 2020](https://doi.org/10.1016/j.parkreldis.2020.06.013)

Nucleus Ambiguus: This motor nucleus innervates the laryngeal muscles via the vagus nerve. Degeneration of nucleus ambiguus neurons causes laryngeal adductor dystonia, producing stridor[@moreno2016]. Post-mortem studies demonstrate significant neuronal loss in this nucleus in MSA patients who had stridor[@iranzo2014].

bfe67bb53c3c532ef4237fa3323691ae27404769

• [Multiple System Atrophy](/diseases/multiple-system-atrophy)
• [Sleep Disorders in Neurodegeneration](/mechanisms/sleep-circadian-dysfunction-comparison)
• [Pre-Bötzinger Complex](/cell-types/pre-bötzinger-complex-expanded)
• [Respiratory Dysfunction in Neurodegeneration](/mechanisms/respiratory-dysfunction-neurodegeneration)

bfe67bb53c3c532ef4237fa3323691ae27404769

Pathway Diagram

The following diagram shows the key molecular relationships involving msa-sleep-disordered-breathing discovered through SciDEX knowledge graph analysis: